ScreenerHero

SYBX Synlogic, Inc.

NAS · US · Healthcare · Biotechnology · synlogictx.com
1.190USD0.00%Mkt Cap: 14.58M $P/E: —

Synlogic, Inc. does not have significant operations. It was previously engaged in the discovery and development of synthetic biotics to treat metabolic diseases. Synlogic, Inc. is based in Winchester, Massachusetts.

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$128.08BUSDP/E 29.4
MRNA
Moderna, Inc.
$78.44BUSD
REGN
Regeneron Pharmaceuticals, Inc.
$76.40BUSDP/E 18.4
ARGX
argenx SE
$57.03BUSDP/E 37.3
ARGX
argenx SE
$58.08BUSDP/E 35.4
UCB
UCB SA
$42.24BUSDP/E 18.0
RVMD
Revolution Medicines, Inc.
$43.05BUSD
ONC
BeOne Medicines AG
$41.41BUSDP/E 65.1
RPRX
Royalty Pharma plc
$32.80BUSDP/E 30.2
ALNY
Alnylam Pharmaceuticals, Inc.
$30.03BUSDP/E 37.8
ROIV
Roivant Sciences Ltd.
$25.10BUSD
BNTX
BioNTech SE
$23.93BUSD
INCY
Incyte Corporation
$22.99BUSDP/E 14.5
GMAB
Genmab A/S
$22.27BUSDP/E 30.7
GMAB
Genmab A/S
$22.54BUSDP/E 28.9
INSM
Insmed Incorporated
$22.22BUSD
ASND
Ascendis Pharma A/S
$15.03BUSDP/E 17.5
JAZZ
Jazz Pharmaceuticals plc
$15.01BUSDP/E 15.8
EXEL
Exelixis, Inc.
$14.48BUSDP/E 18.4
SMMT
Summit Therapeutics Inc.
$14.32BUSD

Key Statistics

Company
Market Cap14.58M USD
Enterprise Value-76.62K USD
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-1.00M USD
Revenue/Share—
Last Price1.190 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees1
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS87166L1008
Valuation
P/E (Trailing)—
P/E (Forward)-2.28
PEG—
EV/EBITDA—
EV/Revenue—
P/S—
P/B1.04
EPS (TTM)-0.06
EPS (Forward)-0.47
52W Range
0.540049% of range1.870
52W High1.870 USD
52W Low0.5400 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-8.47%
ROA-6.51%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-4.36M USD
CapEx (TTM)—
FCF Margin—
FCF Yield-38.34%
Net Debt-13.18M USD
Net Debt/EBITDA—
Balance Sheet
Debt/Equity—
Current Ratio9.19
Quick Ratio9.02
Book Value/Sh1.03 USD
Cash/Share1.08 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateAug 28, 2017
Splits
Last Split1:7
Split DateAug 28, 2017
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.12.25M
Float4.03M
Insiders15.65%
Institutions57.55%
Short Interest
Short Ratio0.3d
Short % Float0.15%
Short % Out.0.07%
Shares Short7.73K
Short (prev mo.)9.48K
Technical
SMA 501.161 (+2.5%)
SMA 2000.8331 (+42.8%)
Beta0.61
S&P 52W Chg16.45%
Avg Vol (30d)66.17K
Avg Vol (10d)30.85K
Technical Indicators
RSI (14)55.9
MACD0.0444
MACD Signal0.0631
MACD Hist.-0.0188
BB Upper1.254 USD
BB Middle1.202 USD
BB Lower1.151 USD
BB Width8.63%
ATR (14)0.0522 USD
Vol Ratio (20d)0.00x